With such high demand for and short supply for GLP-1 agonists, some people have procured them from alternative sources, such as online vendors, medical spas, or compounding pharmacies selling products not evaluated by the FDA, some of which may contain different ingredients
Antioxidant Protection Protects cells from damage and reduces oxidative stress
Some peptides are legal and approved by Health Canada for example, semaglutide (Ozempic) and tirzepatide (Mounjaro) when prescribed by a physician
No prescription formulations of copper peptide GHK-Cu have received FDA approval for any medical indication, and its use is off-label or investigational in clinical contexts
Standard supermarket EVOO contains 50-100 mg/kg of polyphenols
While the clinical impact of GLP-1s on approved indications (e.g., obesity, diabetes, cardiovascular risk) and adjacent indications is being studied extensively in clinical trials, there is limited scientific literature on GLP-1 use, efficacy or persistence outside of clinical trial settings
